Voya Investment Management LLC Adma Biologics, Inc. Transaction History

Voya Investment Management LLC

$80 Billion
Q3 2024

A detailed history of Voya Investment Management LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 625,719 shares of ADMA stock, worth $10.6 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

625,719

Previous 542,242 15.39%

Holding current value

$10.6 Million

Previous $6.06 Million 106.33%

% of portfolio

0.02%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Feb 07, 2025	BUY	$11.21 - $20.03 $935,777 - $1.67 Million	83,477 Added 15.39%	625,719 $12.5 Million
Q3 2024 Nov 14, 2024	BUY	$11.21 - $20.03 $910,778 - $1.63 Million	81,247 Added 15.51%	604,994 $12.1 Million
Q2 2024 Feb 07, 2025	BUY	$5.98 - $11.18 $2.82 Million - $5.27 Million	471,080 Added 661.98%	542,242 $6.06 Million
Q2 2024 Dec 03, 2024	SELL	$5.98 - $11.18 $485,857 - $908,341	-81,247 Reduced 13.43%	523,747 $5.86 Million
Q2 2024 Aug 14, 2024	BUY	$5.98 - $11.18 $2.71 Million - $5.06 Million	452,585 Added 635.99%	523,747 $5.86 Million
Q1 2024 Feb 07, 2025	SELL	$4.4 - $6.74 $2.35 Million - $3.6 Million	-533,832 Reduced 88.24%	71,162 $469,000
Q1 2024 Dec 06, 2024	SELL	$4.4 - $6.74 $2.35 Million - $3.6 Million	-533,832 Reduced 88.24%	71,162 $469,000
Q1 2024 May 15, 2024	SELL	$4.4 - $6.74 $67,465 - $103,344	-15,333 Reduced 17.73%	71,162 $469,000
Q4 2023 Feb 07, 2025	BUY	$3.08 - $4.52 $3,252 - $4,773	1,056 Added 1.24%	86,495 $390,000
Q4 2023 Feb 14, 2024	BUY	$3.08 - $4.52 $3,252 - $4,773	1,056 Added 1.24%	86,495 $390,000
Q3 2023 Feb 07, 2025	BUY	$3.47 - $4.61 $5,114 - $6,795	1,474 Added 1.76%	85,439 $305,000
Q3 2023 Nov 14, 2023	BUY	$3.47 - $4.61 $5,114 - $6,795	1,474 Added 1.76%	85,439 $305,000
Q2 2023 Feb 07, 2025	BUY	$3.12 - $4.22 $39,474 - $53,391	12,652 Added 17.74%	83,965 $309,000
Q2 2023 Aug 14, 2023	BUY	$3.12 - $4.22 $39,474 - $53,391	12,652 Added 17.74%	83,965 $309,000
Q1 2023 Feb 07, 2025	SELL	$3.01 - $3.87 $1.61 Million - $2.07 Million	-533,681 Reduced 88.21%	71,313 $236,000
Q3 2022 Feb 07, 2025	SELL	$2.03 - $2.86 $1.08 Million - $1.53 Million	-533,681 Reduced 88.21%	71,313 $173,000
Q2 2022 Aug 15, 2022	BUY	$1.43 - $2.2 $101,977 - $156,888	71,313 New	71,313 $141,000
Q2 2021 Aug 16, 2021	SELL	$1.51 - $2.07 $44,102 - $60,458	-29,207 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$1.8 - $2.56 $8,809 - $12,528	4,894 Added 20.13%	29,207 $57,000
Q2 2020 Aug 14, 2020	SELL	$2.42 - $3.29 $23,045 - $31,330	-9,523 Reduced 28.14%	24,313 $71,000
Q1 2020 May 15, 2020	BUY	$1.5 - $4.59 $11,710 - $35,834	7,807 Added 29.99%	33,836 $97,000
Q4 2019 Feb 14, 2020	BUY	$3.89 - $5.15 $28,556 - $37,806	7,341 Added 39.28%	26,029 $104,000
Q3 2019 Nov 14, 2019	BUY	$3.19 - $5.39 $22,451 - $37,934	7,038 Added 60.41%	18,688 $83,000
Q2 2019 Aug 14, 2019	BUY	$3.52 - $5.24 $41,008 - $61,046	11,650 New	11,650 $45,000

Others Institutions Holding ADMA

# of Institutions

323

Shares Held

190M

Call Options Held

917K

Put Options Held

91.6K

View Full List

About ADMA BIOLOGICS, INC.

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.33B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

More about ADMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Account

Voya Investment Management LLC Adma Biologics, Inc. Transaction History